Microb-AI-ome Advances AI-Powered Colorectal Cancer Screening

Microb-AI-ome continues making progress towards improving colorectal cancer screening through microbiome analysis and artificial intelligence.

The project investigates whether gut microbiome signatures combined with AI can support earlier and more accurate detection of colorectal cancer while helping reduce unnecessary colonoscopies compared to current screening approaches.

Through its interdisciplinary European consortium, Microb-AI-ome combines expertise in clinical medicine, microbiome science, bioinformatics and federated AI to support the development of privacy-preserving healthcare technologies for future screening programmes.

View project on CORDIS

Why this matters

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, making early and accurate screening critically important. By combining microbiome science with privacy-preserving AI technologies, Microb-AI-ome aims to contribute to more precise, trustworthy and patient-oriented screening strategies across Europe.